VERA compared with CLDX: revenue, margins and what each company keeps, and the suppliers and customers both name

VERAVera Therapeutics, Inc.

Mkt capRevenueRevenue

CLDXCelldex Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

VERAVera Therapeutics, Inc.

CLDXCelldex Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

VERA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±12.4%▼−4.08%×0.33

May 7 '26±8.7%▼−1.95%×0.22

Q1 FY26±14.7%▲+1.61%×0.11

Q3 FY25±21.3%▼−1.03%×0.05

CLDX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.8%▲+0.36%×0.04

May 8 '26±7.6%▲+1.95%×0.25

= impliedVERA realized, solidCLDX realized, hatchedOne scale, both sides: full bar = 22%× = |realized| ÷ impliedSource: market data

Q1 FY26

±13.6%

▼−0.58%

×0.04

Q3 FY25±17.3%▲+7.50%×0.43

VERAVera Therapeutics, Inc.

30.27· pre 30.01· delayed

Mkt cap$2.2BRevenue—Revenue—

CLDXCelldex Therapeutics, Inc.

29.04· pre 29.30· delayed

Pre-marketNov 3 '26delayed

Mkt cap$2.3BRevenue$22,000Q2 FY26Revenue$7MFY24

Compare

Pre-marketNov 3 '26delayed

VERAVera Therapeutics, Inc.

CLDXCelldex Therapeutics, Inc.

30.27pre 30.01delayed

Price

29.04pre 29.30delayed

$2.2B

Mkt cap

$2.3B

—

Revenue

$22,000Q2 FY26

—

Revenue

$7MFY24

VERA30.27vsCLDX29.04Pre-marketNov 3 '26delayed